Biote Investors Sue Cooley, SPAC After Huge Merger Loss

Family trust investors in Biote Corp. have sued Cooley LLP and the "hormone optimization" company's top brass over the $700 million merger Biote completed with a special purpose acquisition company, saying the deal was a "disastrous transaction to divert approximately $70 million of merger consideration to themselves and gain control of an enterprise they did not build."

Related Keywords

Katryna Perera , Biote Corp ,